Comparative study on pregnancy complications: PGT-A vs. IVF-ET with gender-specific outcomes
Frontiers in Endocrinology · 2024
DOI: 10.3389/fendo.2024.1453083 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Frontiers in Endocrinology, 2024. Verfasst von Ling Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Fertilization in Vitro, Pregnancy Outcome, Pregnancy Complications, Preimplantation Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The safety and clinical effectiveness of preimplantation genetic testing for aneuploidy (PGT-A) in improving pregnancy outcomes for sub-fertile patients remains controversial. Potential sex-based differences in the relationship between PGT-A and pregnancy complications have not been investigated, which could guide the appropriate clinical application of PGT-A. In this secondary analysis of data from a multicenter, randomized, controlled, non-inferiority trial (NCT03118141), 940 women who achieved singleton live birth during the trial were included to estimate the between-group differences in pregnancy complications following PGT-A versus conventional in vitro fertilization (IVF) vary with fetal sex. Logistic regression analysis was used to adjust for possible confounders, and subgroup analysis was also performed. Among male fetuses, the risk of maternal preeclampsia was significantly lower after PGT-A compared to conventional IVF treatment (3.37% vs. 7.88%; adjusted OR, 0.40; 95% CI, 0.17-0.92; P = 0.032). However, this protective effect was not observed in pregnancies with female fetuses (3.63% vs. 3.38%; adjusted OR, 1.04; 95% CI, 0.36-3.00; P = 0.937). In addition, no significant sex-dependent differences in the risks of other pregnancy complications or neonatal outcomes were detected between PGT-A and conventional IVF groups ( P > 0.05). In summary, PGT-A was associated with a decreased risk of maternal preeclampsia in singleton pregnancies with male fetuses, highlighting its potential utility in preeclampsia prevention in addition to spontaneous abortion rate reduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Medical Integration and Practice Center, Shandong University, Jinan, Shandong, China.
- State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong, China.
- Department of Otolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Zitieren
APA
Guo, L., Li, X., Guo, A., Wang, Y., Liang, Y., Li, Y., Xu, X., & Lv, H. (2024). Comparative study on pregnancy complications: PGT-A vs. IVF-ET with gender-specific outcomes. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1453083
Vancouver
Guo L, Li X, Guo A, Wang Y, Liang Y, Li Y, et al. Comparative study on pregnancy complications: PGT-A vs. IVF-ET with gender-specific outcomes. Frontiers in Endocrinology. 2024. doi:10.3389/fendo.2024.1453083
BibTeX
@article{Guo2024,
author = {Guo, Ling and Li, Xiao and Guo, Anliang and Wang, Yufeng and Liang, Yue and Li, Yan and Xu, Xinbo and Lv, Hong},
title = {Comparative study on pregnancy complications: PGT-A vs. IVF-ET with gender-specific outcomes},
journal = {Frontiers in Endocrinology},
year = {2024},
doi = {10.3389/fendo.2024.1453083}
}
EUVIMED